Cargando…

Predictive factors for switching in patients with psoriatic arthritis undergoing anti-TNFα, anti-IL12/23, or anti-IL17 drugs: a 15-year monocentric real-life study

OBJECTIVES: We aimed to evaluate the (a) potential predictors of first biological disease-modifying anti-rheumatic drug (bDMARD) failure and (b) factors associated with failure of multiple therapies in psoriatic arthritis (PsA). MATERIALS AND METHODS: We enrolled consecutive PsA patients attending o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lorenzin, Mariagrazia, Ortolan, Augusta, Cozzi, Giacomo, Calligaro, Antonia, Favaro, Maria, Del Ross, Teresa, Doria, Andrea, Ramonda, Roberta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519923/ https://www.ncbi.nlm.nih.gov/pubmed/34136971 http://dx.doi.org/10.1007/s10067-021-05799-0

Ejemplares similares

Mediterranean diet in axial spondyloarthritis: an observational study in an Italian monocentric cohort
por: Ometto, Francesca, et al.
Publicado: (2021)

Correction to: Mediterranean diet in axial spondyloarthritis: an observational study in an Italian monocentric cohort
por: Ometto, Francesca, et al.
Publicado: (2021)

The Genetic Contribution to Drug Response in Spondyloarthritis: A Systematic Literature Review
por: Ortolan, Augusta, et al.
Publicado: (2021)

SARS-CoV-2 Infection in Spondyloarthritis Patients Treated With Biotechnological Drugs: A Study on Serology
por: Ortolan, Augusta, et al.
Publicado: (2021)

Does gender influence clinical expression and disease outcomes in COVID-19? A systematic review and meta-analysis
por: Ortolan, Augusta, et al.
Publicado: (2020)

An update on serum biomarkers to assess axial spondyloarthritis and to guide treatment decision
por: Lorenzin, Mariagrazia, et al.
Publicado: (2020)

Work productivity is associated with disease activity and functional ability in Italian patients with early axial spondyloarthritis: an observational study from the SPACE cohort
por: de Hooge, Manouk, et al.
Publicado: (2016)

Genetics in TNF-TNFR pathway: A complex network causing spondyloarthritis and conditioning response to anti-TNFα therapy
por: Aita, Ada, et al.
Publicado: (2018)

Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab
por: Lorenzin, Mariagrazia, et al.
Publicado: (2015)

IL-23 Blockade in Anti-TNF Refractory IBD: From Mechanisms to Clinical Reality
por: Atreya, Raja, et al.
Publicado: (2022)

The role of IL‐23 and the use of IL‐23 inhibitors in psoriatic arthritis
por: Fragoulis, George E., et al.
Publicado: (2022)

Choosing the Appropriate Target for the Treatment of Psoriatic Arthritis: TNFα, IL-17, IL-23 or JAK Inhibitors?
por: Gialouri, Chrysoula G., et al.
Publicado: (2022)

Spine and Sacroiliac Joints Lesions on Magnetic Resonance Imaging in Early Axial-Spondyloarthritis During 24-Months Follow-Up (Italian Arm of SPACE Study)
por: Lorenzin, Mariagrazia, et al.
Publicado: (2020)

Anti-IL6 treatment of serious COVID-19 disease: A monocentric retrospective experience
por: Castelnovo, Laura, et al.
Publicado: (2021)

Long-term effectiveness and drug survival of golimumab in patients affected by psoriatic arthritis with cutaneous involvement
por: Chimenti, Maria Sole, et al.
Publicado: (2021)

Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis
por: Haugh, Isabel M, et al.
Publicado: (2018)

From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis
por: Silvagni, Ettore, et al.
Publicado: (2021)

The IL-17/IL-23 Axis and Its Genetic Contribution to Psoriatic Arthritis
por: Vecellio, Matteo, et al.
Publicado: (2021)

Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study
por: Ramonda, Roberta, et al.
Publicado: (2021)

Anti-TNF-α effects on anemia in rheumatoid and psoriatic arthritis
por: Corrado, Addolorata, et al.
Publicado: (2017)

IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats
por: Yago, Toru, et al.
Publicado: (2007)

Investigation of association of the IL12B and IL23R genes with psoriatic arthritis
por: Filer, Charlotte, et al.
Publicado: (2008)

Validation of the Italian Version of the Educational Needs Assessment Tool in Rheumatoid Arthritis Patients and Factors Associated with Educational Needs
por: Favero, Marta, et al.
Publicado: (2020)

Evaluating guselkumab: an anti-IL-23 antibody for the treatment of plaque psoriasis
por: Yang, Eric J, et al.
Publicado: (2019)

Determination of Heterogeneous Proteomic and Metabolomic Response in anti-TNF and anti-IL-6 Treatment of Patients with Rheumatoid Arthritis
por: Stepanov, Alexander A., et al.
Publicado: (2023)

Autoimmunogenicity during anti-TNF therapy in patients with psoriasis and psoriatic arthritis
por: Pirowska, Magdalena M., et al.
Publicado: (2015)

Considerations on inhibition of IL‐23 in psoriatic women of childbearing potential
por: Russo, Roberto, et al.
Publicado: (2021)

Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn’s disease
por: Schmitt, Heike, et al.
Publicado: (2019)

IL-36γ Is a Strong Inducer of IL-23 in Psoriatic Cells and Activates Angiogenesis
por: Bridgewood, Charlie, et al.
Publicado: (2018)

Fetuin-A: A Novel Biomarker of Bone Damage in Early Axial Spondyloarthritis. Results of an Interim Analysis of the SPACE Study
por: Favero, Marta, et al.
Publicado: (2023)

IL-23 skin and joint profiling in psoriatic arthritis: novel perspectives in understanding clinical responses to IL-23 inhibitors
por: Nerviani, Alessandra, et al.
Publicado: (2021)

Serum Levels of TNF-α, IL-12/23 p40, and IL-17 in Psoriatic Patients with and without Nail Psoriasis: A Cross-Sectional Study
por: Kyriakou, Aikaterini, et al.
Publicado: (2014)

Inflammatory versus Anti-Inflammatory Profiles in Major Depressive Disorders—The Role of IL-17, IL-21, IL-23, IL-35 and Foxp3
por: Gałecka, Małgorzata, et al.
Publicado: (2021)

Paradoxical Reactions to Anti-TNFα and Anti-IL-17 Treatment in Psoriasis Patients: Are Skin and/or Gut Microbiota Involved?
por: Jiraskova Zakostelska, Zuzana, et al.
Publicado: (2023)

Exosomes secreted by Blastocystis subtypes affect the expression of proinflammatory and anti-inflammatory cytokines (TNFα, IL-6, IL-10, IL-4)
por: Norouzi, Mojtaba, et al.
Publicado: (2022)

Selective targeting of the IL23 pathway: Generation and characterization of a novel high-affinity humanized anti-IL23A antibody
por: Singh, Sanjaya, et al.
Publicado: (2015)

Anti-inflammatory effect of Fumaria parviflora leaves based on TNF-α, IL-1, IL-6 and antioxidant potential
por: Rizvi, Waseem, et al.
Publicado: (2017)

IL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A Therapies
por: Blauvelt, Andrew, et al.
Publicado: (2015)

Serological Biomarkers in Early Axial Spondyloarthritis During 24-Months Follow Up (Italian Arm of Space Study)
por: Lorenzin, Mariagrazia, et al.
Publicado: (2019)

No effect of anti-TNF-α treatment on serum IL-17 in patients with rheumatoid arthritis
por: Sikorska, Dorota, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_msf603f03o5j8ftlimam44ldpr